PE88ICD-11 MMS 2026-01
Assault by exposure to or harmful effects of other or unspecified drug, medicament or biological substance
Index terms
- Assault by exposure to or harmful effects of other or unspecified drug, medicament or biological substance
- homicidal poisoning by exposure to or harmful effects of other or unspecified drug, medicament or biological substance
- Assault by exposure to or harmful effects of systemic antibiotics
Show allHide
- Assault by exposure to or harmful effects of penicillins
- Assault by exposure to or harmful effects of cephalosporins or other beta-lactam antibiotics
- Assault by exposure to or harmful effects of chloramphenicol group
- Assault by exposure to or harmful effects of macrolides
- Assault by exposure to or harmful effects of tetracyclines
- Assault by exposure to or harmful effects of aminoglycosides
- Assault by exposure to or harmful effects of rifampicin
- Assault by exposure to or harmful effects of antifungal antibiotics, systemically used
- Assault by exposure to or harmful effects of other systemic anti-infectives or antiparasitics
- Assault by exposure to or harmful effects of sulfonamides
- Assault by exposure to or harmful effects of antimycobacterial drugs
- Assault by exposure to or harmful effects of antimalarials or drugs acting on other blood protozoa
- Assault by exposure to or harmful effects of other antiprotozoal drugs
- Assault by exposure to or harmful effects of anthelminthics
- Assault by exposure to or harmful effects of antiviral drugs
- Assault by exposure to or harmful effects of hormones or their synthetic substitutes or antagonists, not elsewhere classified
- Assault by exposure to or harmful effects of glucocorticoids or synthetic analogues
- Assault by exposure to or harmful effects of thyroid hormones or substitutes
- Assault by exposure to or harmful effects of antithyroid drugs
- Assault by exposure to or harmful effects of insulin or oral hypoglycaemic drugs
- Assault by exposure to or harmful effects of antidiabetic drugs
- Assault by exposure to or harmful effects of oral contraceptives
- Assault by exposure to or harmful effects of other estrogens or progestogens
- Assault by exposure to or harmful effects of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified
- Assault by exposure to or harmful effects of androgens or anabolic congeners
- Assault by exposure to or harmful effects of unspecified hormones or synthetic substitutes
- Assault by exposure to or harmful effects of anterior pituitary hormones
- Assault by exposure to or harmful effects of adenohypophyseal hormones
- Assault by exposure to or harmful effects of other hormones or synthetic substitutes
- Assault by exposure to or harmful effects of unspecified hormone antagonists
- Assault by exposure to or harmful effects of other hormone antagonists
- Assault by exposure to or harmful effects of drugs primarily affecting the autonomic nervous system
- Assault by exposure to or harmful effects of anticholinesterase agents
- Assault by exposure to or harmful effects of other parasympathomimetics
- Assault by exposure to or harmful effects of cholinergics
- Assault by exposure to or harmful effects of ganglionic blocking drugs
- Assault by exposure to or harmful effects of other parasympatholytics or spasmolytics
- Assault by exposure to or harmful effects of anticholinergics or antimuscarinics
- Assault by exposure to or harmful effects of predominantly alpha-adrenoreceptor agonists
- Assault by exposure to or harmful effects of predominantly beta-adrenoreceptor agonists
- Assault by exposure to or harmful effects of alpha-adrenoreceptor antagonists
- Assault by exposure to or harmful effects of beta-adrenoreceptor antagonists
- Assault by exposure to or harmful effects of centrally-acting or adrenergic-neuron-blocking agents
- Assault by exposure to or harmful effects of agents primarily affecting blood constituents
- Assault by exposure to or harmful effects of diphenhydramine
- Assault by exposure to or harmful effects of other H1-receptor antagonists
- Assault by exposure to or harmful effects of antiallergic or antiemetic drugs
- Assault by exposure to or harmful effects of antineoplastic antimetabolites
- Assault by exposure to or harmful effects of antineoplastic natural products
- Assault by exposure to or harmful effects of other antineoplastic drugs
- Assault by exposure to or harmful effects of immunosuppressive agents
- Assault by exposure to or harmful effects of vitamin B12, folic acid or other anti-megaloblastic-anaemia preparations
- Assault by exposure to or harmful effects of enzymes
- Assault by exposure to or harmful effects of iron or its compounds
- Assault by exposure to or harmful effects of anticoagulants
- Assault by exposure to or harmful effects of antithrombotic drugs
- Assault by exposure to or harmful effects of platelet aggregation inhibitors
- Assault by exposure to or harmful effects of thrombolytic drug
- Assault by exposure to or harmful effects of anticoagulant antagonists, vitamin K or other coagulants
- Assault by exposure to or harmful effects of other fibrinolysis-affecting drugs
- Assault by exposure to or harmful effects of natural blood or blood products
- Assault by exposure to or harmful effects of acidifying or alkalising agents
- Assault by exposure to or harmful effects of other primarily systemic agents, not elsewhere classified
- Assault by exposure to or harmful effects of plasma substitutes
- Assault by exposure to or harmful effects of agents primarily affecting the cardiovascular system
- Assault by exposure to or harmful effects of cardiac-stimulant glycosides or drugs of similar action
- Assault by exposure to or harmful effects of calcium-channel blockers
- Assault by exposure to or harmful effects of other antidysrhythmic drugs
- Assault by exposure to or harmful effects of nitroglycerin, nitroglycerol, medicinal
- Assault by exposure to or harmful effects of other coronary vasodilators
- Assault by exposure to or harmful effects of angiotensin-converting-enzyme inhibitors
- Assault by exposure to or harmful effects of other antihypertensive drugs
- Assault by exposure to or harmful effects of antihyperlipidemic or antiarteriosclerotic drugs
- Assault by exposure to or harmful effects of peripheral vasodilators
- Assault by exposure to or harmful effects of antivaricose drugs, including sclerosing agents
- Assault by exposure to or harmful effects of agents primarily affecting the gastrointestinal system
- Assault by exposure to or harmful effects of histamine H2-receptor blockers
- Assault by exposure to or harmful effects of other antacids or anti-gastric-secretion drugs
- Assault by exposure to or harmful effects of stimulant laxatives
- Assault by exposure to or harmful effects of saline or osmotic laxatives
- Assault by exposure to or harmful effects of other laxatives
- Assault by exposure to or harmful effects of digestants
- Assault by exposure to or harmful effects of antidiarrhoeal drugs
- Assault by exposure to or harmful effects of emetics
- Assault by exposure to or harmful effects of agents primarily acting on smooth or skeletal muscles or the respiratory system
- Assault by exposure to or harmful effects of oxytocic drugs
- Assault by exposure to or harmful effects of skeletal muscle relaxants
- Assault by exposure to or harmful effects of neuromuscular blocking agents
- Assault by exposure to or harmful effects of unspecified drugs acting on muscles
- Assault by exposure to or harmful effects of other drugs acting on muscles
- Assault by exposure to or harmful effects of antitussives
- Assault by exposure to or harmful effects of expectorants
- Assault by exposure to or harmful effects of other anti-common-cold drugs
- Assault by exposure to or harmful effects of salbutamol
- Assault by exposure to or harmful effects of aminophylline, theophylline
- Assault by exposure to or harmful effects of terbutaline
- Assault by exposure to or harmful effects of antiasthmatics, not elsewhere classified
- Assault by exposure to or harmful effects of topical agents primarily affecting skin or mucous membrane or ophthalmological, otorhinolaryngological or dental drugs
- Assault by exposure to or harmful effects of topical corticosteroid preparations
- Assault by exposure to or harmful effects of iodine, antiseptic
- Assault by exposure to or harmful effects of silver nitrate
- Assault by exposure to or harmful effects of other local antifungal, anti-infective or anti-inflammatory drugs
- Assault by exposure to or harmful effects of antipruritics
- Assault by exposure to or harmful effects of methyl salicylate
- Assault by exposure to or harmful effects of other local astringents or local detergents
- Assault by exposure to or harmful effects of emollients, demulcents or protectants
- Assault by exposure to or harmful effects of podophyllin
- Assault by exposure to or harmful effects of keratolytics, keratoplastics, or other hair treatment drugs or preparations
- Assault by exposure to or harmful effects of ophthalmological drugs or preparations
- Assault by exposure to or harmful effects of otorhinolaryngological drugs or preparations
- Assault by exposure to or harmful effects of fluoride preparations
- Assault by exposure to or harmful effects of other dental drugs, topically applied
- Assault by exposure to or harmful effects of camphor
- Assault by exposure to or harmful effects of agents primarily affecting water-balance or mineral or uric acid metabolism
- Assault by exposure to or harmful effects of mineralocorticoids
- Assault by exposure to or harmful effects of mineralocorticoids antagonists
- Assault by exposure to or harmful effects of loop diuretics
- Assault by exposure to or harmful effects of high-ceiling diuretics
- Assault by exposure to or harmful effects of carbonic-anhydrase inhibitors
- Assault by exposure to or harmful effects of benzothiadiazine derivatives
- Assault by exposure to or harmful effects of thiazides
- Assault by exposure to or harmful effects of other diuretics
- Assault by exposure to or harmful effects of electrolytic, caloric or water-balance agents
- Assault by exposure to or harmful effects of mineral salts, not elsewhere classified
- Assault by exposure to or harmful effects of drugs affecting uric acid metabolism
- Assault by exposure to or harmful effects of vitamin D or derivatives
- Assault by exposure to or harmful effects of bisphosphonates
- Assault by exposure to or harmful effects of appetite depressants
- Assault by exposure to or harmful effects of antidotes or chelating agents, not elsewhere classified
- Assault by exposure to or harmful effects of disulfiram
- Assault by exposure to or harmful effects of alcohol deterrents, not elsewhere classified
- Assault by exposure to or harmful effects of X-ray contrast media
- Assault by exposure to or harmful effects of MRI contrast agents
- Assault by exposure to or harmful effects of agents used for other scanning techniques
- Assault by exposure to or harmful effects of other diagnostic agents
- Assault by exposure to or harmful effects of lipotropic drugs
- Assault by or harmful exposure to harmful effects of vitamins or pharmaceutical excipients, not elsewhere classified
- Assault by or harmful exposure to herbal preparations or formulas
- Assault by or harmful exposure to dietary supplements, vitamins or minerals
- Assault by or harmful exposure to complementary or traditional medicines, not elsewhere classified
- Assault by or harmful exposure to complementary or traditional medicines, unspecified
- Assault by or harmful exposure to vaccines, immunoglobulins or other biological substances
- Assault by or harmful exposure to BCG vaccine
- Assault by or harmful exposure to typhoid or paratyphoid vaccine
- Assault by or harmful exposure to cholera vaccine
- Assault by or harmful exposure to plague vaccine
- Assault by or harmful exposure to tetanus vaccine
- Assault by or harmful exposure to diphtheria vaccine
- Assault by or harmful exposure to Haemophilus influenzae type B vaccines
- assault by or harmful exposure to H. influenzae type B vaccines
- Assault by or harmful exposure to pertussis vaccine, including combinations with a pertussis component
- Assault by or harmful exposure to mixed bacterial vaccines without a pertussis component
- Assault by or harmful exposure to other or unspecified bacterial vaccines
- Assault by or harmful exposure to smallpox vaccines
- Assault by or harmful exposure to measles vaccines
- Assault by or harmful exposure to mumps vaccines
- Assault by or harmful exposure to rubella vaccines
- Assault by or harmful exposure to polio vaccines
- Assault by or harmful exposure to yellow fever vaccines
- Assault by or harmful exposure to hepatitis A vaccines
- Assault by or harmful exposure to hepatitis B vaccines
- Assault by or harmful exposure to influenza vaccines
- Assault by or harmful exposure to rotavirus vaccines
- Assault by or harmful exposure to human papillomavirus vaccines
- Assault by or harmful exposure to other viral vaccines
- Assault by or harmful exposure to rickettsial vaccines
- Assault by or harmful exposure to protozoal vaccines
- Assault by or harmful exposure to hepatitis B immune globulin
- Assault by or harmful exposure to antivenin or antivenom
- Assault by or harmful exposure to immunoglobulin, not elsewhere classified
- Assault by or harmful exposure to other specified vaccines
- Assault by or harmful exposure to unspecified vaccines
Exclusions from above levels
- http://id.who.int/icd/entity/1583926619 – Substances associated with injury or harm in therapeutic use
Sibling codes
PE80– Assault by exposure to or harmful effects of opioids or related analgesicsPE81– Assault by exposure to or harmful effects of sedative, hypnotic drugs or other CNS depressantsPE82– Assault by exposure to or harmful effects of psychostimulantsPE83– Assault by exposure to or harmful effects of cannabinoids or hallucinogensPE84– Assault by exposure to or harmful effects of analgesics, antipyretics or nonsteroidal anti-inflammatory drugsPE85– Assault by exposure to or harmful effects of antidepressantsPE86– Assault by exposure to or harmful effects of antipsychoticsPE87– Assault by exposure to or harmful effects of antiepileptics or antiparkinsonism drugsPE89– Assault by exposure to or harmful effects of multiple drugs, medicaments or biological substancesPE8Y– Other specified assault by exposure to or harmful effects of drugs, medicaments or biological substancesPE8Z– Assault by exposure to or harmful effects of drugs, medicaments or biological substances, unspecified
Foundation entity
Assault by exposure to or harmful effects of other or unspecified drug, medicament or biological substance – http://id.who.int/icd/entity/1408645785
Allowed postcoordination axes
Part of: 23: External causes of morbidity or mortality